SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-161664
Filing Date
2024-06-14
Accepted
2024-06-14 16:30:56
Documents
13
Period of Report
2024-06-11
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d805555d8k.htm   iXBRL 8-K 25602
  Complete submission text file 0001193125-24-161664.txt   152600

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bior-20240611.xsd EX-101.SCH 2869
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bior-20240611_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bior-20240611_pre.xml EX-101.PRE 11720
16 EXTRACTED XBRL INSTANCE DOCUMENT d805555d8k_htm.xml XML 3778
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)

IRS No.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39334 | Film No.: 241045352
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)